Election committee for Vigmed Holding AB (publ)
The following people have been appointed as members of Vigmed Holding’s election committee for the Annual General Meeting in 2017:
Henrik Blomquist, representing Bure Equity AB
Per Knutsson, representing Soliver Ltd
Mikael Karlsson, representing the Karlsson family (Cecilia and Amanda Karlsson)
Sten Dahlborg, Chairman of the Board
The appointments have been made in accordance with the instructions regarding principles for the appointment of the company election committee which were determined at the Annual General Meeting of Vigmed Holding AB (publ) on May 12, 2016.
The Annual General Meeting of Vigmed Holding AB (publ) will be held on May 11, 2017 in Helsingborg.
Shareholders who wish to have an item considered at the Annual General Meeting can submit a request to the Board to this effect. Such a request for an item to be considered is to be sent to Vigmed Holding AB (publ), Att: Chairman of the Board, Garnisonsgatan 10, 254 66 Helsingborg, and must have been received by the Board no later than seven weeks before the Annual General Meeting, or otherwise in such good time that the matter, where necessary, can be included in the notice to attend the Annual General Meeting.
Helsingborg, November 11, 2016
Vigmed Holding AB (publ)
For further information contact:
Chairman of the Board Sten Dahlborg, +46 708-369 419
CEO Henrik Olsen, +46 763-497 364
This information is information that Vigmed Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 8.30 am CET on November 11, 2016.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk of cross infections with blood-borne infectious diseases by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor.Additional information about the company can be found on Vigmed’s website: www.vigmed.com/investor